{"id":419,"date":"2019-11-03T21:37:03","date_gmt":"2019-11-03T19:37:03","guid":{"rendered":"http:\/\/cratia.com\/?post_type=countries&#038;p=419"},"modified":"2020-11-18T17:30:05","modified_gmt":"2020-11-18T15:30:05","slug":"registracziya-lekarstvennyh-sredstv","status":"publish","type":"countries","link":"https:\/\/cratia.com\/en\/countries\/ukraina\/registracziya-lekarstvennyh-sredstv\/","title":{"rendered":"Registration of medicines"},"content":{"rendered":"<p><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">For import and sale of medicines on the territory of Ukraine it is required to obtain the state registration and fulfil specific requirements regarding quality and safety.\u00a0<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">Since 2005, the legislation of Ukraine in relation to the registration and circulation of medicinal products started harmonisation with EU. The general requirements for documentation and expert assessment procedures are similar to the European ones, but there are many national features that significantly affect all regulatory processes.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">The definition of \u201cmedicinal product\u201d includes:<\/span><\/p>\n<ul style=\"text-align: justify;\">\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">finished medicinal and immunobiological products;\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">in-bulk products;\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Active Pharmaceutical Ingredients (APIs).<\/span><\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">As of the end of 2019, there are three different registration procedures for medicinal products:<\/span><\/p>\n<ul style=\"text-align: justify;\">\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Order No. 426, which describes the general requirements for the registration of medicinal products, including simplified (accelerated) registration of medicinal products for the treatment of socially dangerous diseases;\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Order No. 1245, which establishes a simplified registration procedure (so-called \u201crecognition\u201d) for medicinal products registered by the competent authorities of the United States of America, Switzerland, Japan, Australia, Canada, and medicinal products registered under a centralized procedure by the competent authority of the European Union;\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Order No. 721, which establishes the procedure for the registration of medicinal products that are subject to purchase by specialized international organizations (so-called \u201cauthentication\u201d).\u00a0<\/span><\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">The Applicant (Marketing Authorization Holder &#8211; MAH) can choose the procedure. However, registration under Orders No. 1245 and No. 721 implies certain conditions, and is applicable only to certain groups of medicinal products.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">The MAH for registration can be both a resident and a non-resident of Ukraine (for example, the manufacturer itself). According to the legislation, MAH is responsible for the quality, safety and efficacy of the medicinal product in Ukraine.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">The non-resident MAH is not required to create a representative office or to have another person in Ukraine, however, it is required to:<\/span><\/p>\n<ul style=\"text-align: justify;\">\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">establish and maintain a pharmacovigilance system in Ukraine, designate a local contact person responsible for pharmacovigilance in Ukraine (LCP);<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">designate a person in Ukraine who will be responsible for the quality of the medicinal product.<\/span><\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">MAH\u2019s obligations for regulatory affairs, safety and quality management can be outsourced to Cratia.\u00a0<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">\u00a0<\/span><\/p>\n<p style=\"text-align: justify;\"><b>Registration dossier<\/b><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">The CTD format has been introduced in Ukraine since 2005, and for more than 10 years it has been the only applicable format, with the exception of registration procedures under Orders No. 1245 and No. 721. The CTD format requirements are based on ICH (The International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use) standards, but the registration dossier is still submitted in paper form.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">The documentation for the standard procedure for a new registration under Order No. 426 includes the following parts:<\/span><\/p>\n<ul style=\"text-align: justify;\">\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">National Application form;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Registration form (legal and administrative documentation amending the Application);<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Registration dossier in CTD format consisting of 5 Modules (Modules 2-5 comply with ICH CTD requirements);<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Translation of specific parts of the registration dossier into Ukrainian or Russian;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Specific national documents:<\/span>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">expert reports on non-clinical and clinical data, prepared according to national forms and recommendations;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">MQC (MKK or AND) \u2013 methods for quality control of a medicinal product, which include the composition of the product, specification for release and shelf-life, a detailed description of the methods, information about the manufacturers, description of the packaging system, shelf life and storage conditions;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">instructions for use \u2013 information on the use of a medicinal product, which is most often supplied in the form of a leaflet;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">text for the package labeling \u2013 a description of the information printed on the primary and secondary packaging of the medicinal product.<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">The following documents are submitted in the Ukrainian language:<\/span><\/p>\n<ul style=\"text-align: justify;\">\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Application form;\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">all documents from Registration form;\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Module 1 (translation);\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">parts of Module 2, in required;\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">parts of Module 3.2.P;\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">translation of some other parts of the dossier;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">specific national documents (reports, MQC, instructions for use, packaging labeling).<\/span><\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">There are strict requirements for registration dossiers: the number of pages in a file, cross-numbering and table of contents, sidebars etc.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">Administrative documentation is submitted in a properly legalised form. The registration dossier must be submitted in paper form, in some cases parts of the dossier are allowed to be submitted in electronic form.<\/span><\/p>\n<p>&nbsp;<\/p>\n<p style=\"text-align: justify;\"><b>New registration<\/b><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">Depending on the type of medicinal product, indications for use, market authorisation status and other characteristics, various types of Applications and different expert evaluation periods are used. It should be noted that Ukraine follows the harmonization procedure with the EU, but still has its own independent legislation and expert evaluation procedure.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">Medicines are classified under the following types:<\/span><\/p>\n<ul style=\"text-align: justify;\">\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">full Application (stand-alone dossier);<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">generic, hybrid medicinal product or biosimilar;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">well-established use (WEU);<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">fixed combination;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">informed consent;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">traditional medicinal product;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">in-bulk.<\/span><\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">For each type of a medicinal product, the legislation stipulates certain requirements for the content of the registration dossier, the timing of the expert evaluation and other issues.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">Registration procedure begins with the submission of the Application form to the single-window system of the Ministry of Health, and ends with the signing of the Order of the Ministry of Health and receiving of the hard original Marketing Authorization Certificate.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">Both MAH and competent authority must follow strict timelines as soon as the Application form is submitted. If the MAH does not perform a specific action, or submits the necessary documents not in the full amount, or the documentation is filled incorrectly, then the registration procedure may be canceled, and all paid state fees will not be returned.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">During the registration, it is necessary to make several payments to the accounts of state bodies, including:<\/span><\/p>\n<ol style=\"text-align: justify;\">\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">payment of the state fee for a medicinal product registration to the account of the State Treasury of Ukraine;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">payment of the cost of expert works to the account of the State Expert Center;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">(if necessary) payment of the cost of laboratory quality control of a medicinal product samples to the account of an authorized laboratory.<\/span><\/li>\n<\/ol>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">Terms of expert evaluation of the registration dossier for a medicinal product depending on the type of Applications and chosen registration route:<\/span><\/p>\n<ul style=\"text-align: justify;\">\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">210 business (working) days: a medicinal product submitted for registration on a full Application (stand-alone dossier); medical immunobiological products and biosimilars;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">90 business days: for other types of medicinal products (generics, well-established and other types);<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">45 working days: for orphan products and medicinal products for the treatment of socially dangerous diseases (HIV, viral hepatitis, tuberculosis, cancer etc.);<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">10 business days (assessment under Order 1245): for medicinal products registered by the competent authorities of the United States of America, Switzerland, Japan, Australia, Canada and medicinal products registered by the competent authority of the European Union according to a centralized procedure;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">5 business days (assessment under Order No. 721): for medicinal products subject to purchase by specialized international organizations.<\/span><\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">The indicated timelines are duration of expert evaluation of materials, and do not include:<\/span><\/p>\n<ul style=\"text-align: justify;\">\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">period of the initial assessment of the Application form and registration form;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">period for payment of state fees and receiving payment confirmation;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">period for answers on the deficiencies;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">time needed for import of samples and standards, laboratory analysis (if required);<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">finalizing actions after expert evaluation (verification\/proofreading of draft of registration certificate and its annexes);<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">signing the Order of Ministry of Health on the registration of a medicinal product.<\/span><\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">The realistic timelines of the registration procedure includes the expert evaluation period, plus several months for the mentioned actions.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">\u00a0<\/span><\/p>\n<p style=\"text-align: justify;\"><b>Language and labeling<\/b><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">The only official language in Ukraine is Ukrainian. Suggested text for labeling and instructions for use (leaflet, package insert) of the medicinal product are submitted for expert evaluation in Ukrainian language.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">The labeling information and instructions for use are assessed during the state registration and approved as the annexes to the registration certificate. During the expert evaluation the text may be amended repeatedly at the discretion of state experts. Other languages \u200b\u200b(for example, Russian, English) may also be presented on the packaging and in the instructions provided the complete identity of the text to the Ukrainian text.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">After receiving a Marketing Authorization, but before importing the medicinal product, the Applicant should develop graphic packaging mock-ups and submit them for registration to the Unified Automated Information System (UAIS) of the State Service of Ukraine on Medicines and Drugs Control.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">Layouts submitted for registration should include:<\/span><\/p>\n<ul style=\"text-align: justify;\">\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">approved text;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">graphical representation of the precise placement of text and other packaging elements;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">size and shape of layouts;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">graphical representation and\/or description of security elements;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">designation of printing inks that will be used in the production;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">inscriptions in Braille and their placement (if applicable);<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">barcode;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">positioning of technical elements;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">other additional information (if necessary).<\/span><\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">The packaging of a medicinal product is checked at the stage of import of the batch (obtaining an opinion on the quality of the imported batch), and the slightest discrepancy can lead to deficiency letter, suspension of the quality conclusion issuance and corrective actions.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">Exceptions are medicinal products purchased by specialized international organizations, which are allowed to be supplied in packaging labeled in the original language.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">\u00a0<\/span><\/p>\n<p style=\"text-align: justify;\"><b>Marketing Authorization<\/b><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">Marketing Authorization after the initial registration is issued for a period of 5 years. After renewal, an unlimited Marketing Authorization is issued (unless the Ministry of Health decides to conduct additional renewal after 5 years for justified reasons related to pharmacovigilance).<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">Marketing Authorization consists of:<\/span><\/p>\n<ul style=\"text-align: justify;\">\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">the Marketing Authorization itself issued on a special hologram form;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">appendix to the Marketing Authorization: methods of quality control of a medicinal product;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">appendix to the Marketing Authorization: instructions for human use of a medicinal product;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">appendix to the Marketing Authorization: labeling of packaging materials.<\/span><\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">All amendments (of any type) are also an integral part of the Marketing Authorization.<\/span><\/p>\n<p>&nbsp;<\/p>\n<p style=\"text-align: justify;\"><b>Maintenance of Marketing Authorization and changes<\/b><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">In Ukraine there are no monthly or annual payments related to maintaining registration. However, the Applicant must maintain a pharmacovigilance system and a quality management system in Ukraine.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">Therefore, the Applicant must provide:<\/span><\/p>\n<ul style=\"text-align: justify;\">\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">continuous presence of a person responsible for pharmacovigilance;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">continuous presence of a person responsible for quality, safety and efficacy.<\/span><\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">Fulfillment of the Applicant&#8217;s obligations with regard to maintaining quality and safety may be outsourced to Cratia Ltd.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">All changes to the Marketing Authorization are made by submitting the Application and a package of documents, payment of the cost of expert evaluation, approval by the Order of the Ministry of Health of Ukraine.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">The Applicant must submit an Application for Variations related to safety to the instructions for human use of a medicinal product within the 60 calendar days from the date of receipt of information on amendment necessity.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">The types of variations are similar to those in the EU:<\/span><\/p>\n<ul style=\"text-align: justify;\">\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">correction of a technical error: correction of inconformity made during the registration, renewal or amendment procedure;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">change of the Applicant (Holder) of the Marketing Authorization;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">type IA: minor variations that do not have a significant impact on quality, safety and efficacy;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">type \u0406\u0410-IN: type IA variations with immediate notification;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">type IB: minor variations, which are neither a type IA variation nor a type II variation;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">type II: changes that affect quality, safety and efficacy;<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">changes that lead to a new registration.<\/span><\/li>\n<\/ul>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">The concept of \u201cnotification\u201d in Ukraine differs from European practice: in fact, \u201cnotification\u201d changes do not imply any errors or questions of the competent authorities, since a comment means refusal to conduct an expert evaluation.<\/span><\/p>\n<p>&nbsp;<\/p>\n<p style=\"text-align: justify;\"><b>Marketing Authorization Renewal<\/b><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">It is possible to submit an Application for renewal of\u00a0 marketing authorization not later than 180 calendar days before its expiry (the recommended period for application is 12 months).<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">Renewal process starts from the moment the Application is submitted to the Ministry of Health of Ukraine, and ends by approving the renewal of the authorization by the Order of the Ministry of Health of Ukraine and the issuance of a new Marketing Authorization. In this case, the Marketing Authorization number remains the same.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">\u00a0A significantly smaller package of documents is required for renewal procedure compared to an initial registration. During renewal process, the main emphasis is made on the managing medicinal product safety, i.e., on the pharmacovigilance system documentation and instructions for human use of the medicinal product.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">Before filing the Renewal Application, it is necessary to submit separate Applications for all changes. Such submitted Applications (variations and renewal) undergo expert evaluation concurrently and independently.<\/span><\/p>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">Once renewed, the Marketing Authorisation shall be valid for an unlimited period, unless the Ministry of Health decides to conduct additional renewal procedure after 5 years on justified reasons relating to pharmacovigilance.<\/span><\/p>\n<p>&nbsp;<\/p>\n<p style=\"text-align: justify;\"><b>Cratia provides professional services on establishment and maintenance of state registration of medicines in Ukraine. We have an excellent knowledge of national legislation, necessary experience and resources.\u00a0\u00a0<\/b><\/p>\n<p><span style=\"font-weight: 400;\">To start cooperation or get advice, please contact us by phone: +38 068 064-78-31, +38 044 223-61-67, by e-mail: <a href=\"mailto:info@cratia.ua\">info@cratia.ua<\/a>, or visit <a href=\"\/en\/contacts\/\">our office<\/a>.\u00a0<\/span><\/p>","protected":false},"featured_media":0,"parent":124,"menu_order":1,"template":"","class_list":["post-419","countries","type-countries","status-publish","hentry"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/cratia.com\/en\/wp-json\/wp\/v2\/countries\/419","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cratia.com\/en\/wp-json\/wp\/v2\/countries"}],"about":[{"href":"https:\/\/cratia.com\/en\/wp-json\/wp\/v2\/types\/countries"}],"up":[{"embeddable":true,"href":"https:\/\/cratia.com\/en\/wp-json\/wp\/v2\/countries\/124"}],"wp:attachment":[{"href":"https:\/\/cratia.com\/en\/wp-json\/wp\/v2\/media?parent=419"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}